Research Diagnosis Related Groups (DRG) level SNF discharge quality outcomes for McLaren Bay Region located at 1900 Columbus Ave, Bay City, MI, 48708 & includes data from NPIs 1831163070, 1528031226, 1801860218
Dexur analyzed Q2 2019 (April to June 2019) Medicare claims data to benchmark skilled nursing facilities (SNF) discharges rates for McLaren Bay Region compared to state, national and top peer hospitals at the Diagnosis Related Group (DRG) level.
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| All Inpatient | 1,882 | 1,765 | ||||||||||
| Surgical | 527 | 515 | ||||||||||
| Non Surgical | 1,355 | 1,250 | ||||||||||
| Cardiovascular | 572 | 540 | ||||||||||
| General Medicine | 223 | 199 | ||||||||||
| Orthopedics | 188 | 183 | ||||||||||
| Pulmonology | 181 | 170 | ||||||||||
| Gastroenterology & Endocrinology | 147 | 137 | ||||||||||
| Urology | 136 | 126 | ||||||||||
| Neurology | 123 | 113 | ||||||||||
| General Surgery | 113 | 107 | ||||||||||
| Psychiatry & Mental Disorders | 92 | 87 | ||||||||||
| Oncology & Hematology | 42 | 40 | ||||||||||
| Spine | 33 | 33 | ||||||||||
| Obstetrics & Gynecology | 14 | 13 |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Heart Failure And Shock | ||||||||||||
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 292: HEART FAILURE AND SHOCK WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Acute Myocardial Infarction | ||||||||||||
| DRG 280: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 281: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 282: ACUTE MYOCARDIAL INFARCTION, DISCHARGED ALIVE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Percutaneous Cardiovascular Procedures With Coronary Artery/Stent | ||||||||||||
| DRG 247: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 246: PERCUTANEOUS CARDIOVASCULAR PROCEDURES WITH DRUG-ELUTING STENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) OR 4+ VESSELS OR STENTS | ||||||||||||
| Cardiac Arrhythmia And Conduction Disorders | ||||||||||||
| DRG 309: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 310: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Circulatory Disorders Except Ami With Cardiac Catheterization | ||||||||||||
| DRG 287: CIRCULATORY DISORDERS EXCEPT AMI, WITH CARDIAC CATETERIZATION WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Permanent Cardiac Pacemaker Implant | ||||||||||||
| DRG 243: PERMANENT CARDIAC PACEMAKER IMPLANT WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Syncope And Collapse | ||||||||||||
| DRG 312: SYNCOPE AND COLLAPSE | ||||||||||||
| Chest Pain | ||||||||||||
| DRG 313: CHEST PAIN | ||||||||||||
| Coronary Bypass | ||||||||||||
| Peripheral Vascular Disorders | ||||||||||||
| Other Vascular Procedures | ||||||||||||
| Endovascular Procedures | ||||||||||||
| Atherosclerosis | ||||||||||||
| DRG 303: ATHEROSCLEROSIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hypertension |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Septicemia Or Severe Sepsis | ||||||||||||
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 872: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Nutritional And Miscellaneous Metabolic Disorders | ||||||||||||
| DRG 641: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Cellulitis | ||||||||||||
| DRG 603: CELLULITIS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Aftercare | ||||||||||||
| DRG 949: AFTERCARE WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Disorders Of Liver Except Malignancy, Cirrhosis And Alcoholic Hepatitis | ||||||||||||
| DRG 442: DISORDERS OF LIVER EXCEPT MALIGNANCY, CIRRHOSIS OR ALCOHOLIC HEPATITIS WITH COMPLICATION OR COMORBIDITY (CC) |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Major Hip And Knee Joint Replacement Or Reattachment Of Lower Extremity | ||||||||||||
| DRG 470: MAJOR JOINT REPLACEMENT OR REATTACHMENT OF LOWER EXTREMITY WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Hip And Femur Procedures Except Major Joint | ||||||||||||
| Aftercare, Musculoskeletal System And Connective Tissue | ||||||||||||
| DRG 560: AFTERCARE, MUSCULOSKELETAL SYSTEM AND CONNECTIVE TISSUE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Medical Back Problems | ||||||||||||
| DRG 552: MEDICAL BACK PROBLEMS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Musculoskeletal System And Connective Tissue O.R. Procedures | ||||||||||||
| Revision Of Hip Or Knee Replacement |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease | ||||||||||||
| DRG 190: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 191: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 192: CHRONIC OBSTRUCTIVE PULMONARY DISEASE WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Simple Pneumonia And Pleurisy | ||||||||||||
| DRG 194: SIMPLE PNEUMONIA AND PLEURISY WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Pulmonary Edema And Respiratory Failure | ||||||||||||
| DRG 189: PULMONARY EDEMA AND RESPIRATORY FAILURE | ||||||||||||
| Respiratory Infections And Inflammations | ||||||||||||
| Bronchitis And Asthma |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Esophagitis, Gastroenteritis And Miscellaneous Digestive Disorders | ||||||||||||
| DRG 392: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| G.I.Hemorrhage | ||||||||||||
| DRG 378: G.I. HEMORRHAGE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Diabetes | ||||||||||||
| DRG 638: DIABETES WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| G.I. Obstruction |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Renal Failure | ||||||||||||
| DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 683: RENAL FAILURE WITH COMPLICATION OR COMORBIDITY (CC) | ||||||||||||
| Kidney And Urinary Tract Infections | ||||||||||||
| DRG 690: KIDNEY AND URINARY TRACT INFECTIONS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| DRG 689: KIDNEY AND URINARY TRACT INFECTIONS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Other Kidney And Urinary Tract Diagnoses | ||||||||||||
| DRG 698: OTHER KIDNEY AND URINARY TRACT DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Kidney And Ureter Procedures |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracranial Hemorrhage Or Cerebral Infarction | ||||||||||||
| DRG 065: INTRACRANIAL HEMORRHAGE OR CEREBRAL INFARCTION WITH COMPLICATION OR COMORBIDITY (CC) OR TPA IN 24 HOURS | ||||||||||||
| Degenerative Nervous System Disorders | ||||||||||||
| DRG 057: DEGENERATIVE NERVOUS SYSTEM DISORDERS WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) | ||||||||||||
| Transient Ischemia | ||||||||||||
| DRG 069: TRANSIENT ISCHEMIA |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Extracranial Procedures | ||||||||||||
| Infections And Parasitic Diseases With O.R. Procedure | ||||||||||||
| Extensive O.R. Procedure Unrelated To Principal Diagnosis | ||||||||||||
| Peripheral And Cranial Nerve And Other Nervous System Procedures |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Psychoses | ||||||||||||
| DRG 885: PSYCHOSES |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Red Blood Cell Disorders |
| Total Hospitalizations (Apr 2019 to Jun 2019) | Total Hospitalizations After Exclusion | Total Users | SNF Discharge Rate (%) | Michigan Total Hospitalizations (Apr 2019 to Jun 2019) | Michigan Total Hospitalizations After Exclusion | Michigan Total Users | Michigan SNF Discharge Rate (%) | National Total Hospitalizations (Apr 2019 to Jun 2019) | National Total Hospitalizations After Exclusion | National Total Users | National SNF Discharge Rate (%) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spinal Fusion Except Cervical | ||||||||||||
| DRG 460: SPINAL FUSION EXCEPT CERVICAL WITHOUT MAJOR COMPLICATION OR COMORBIDITY (MCC) |